Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) Attention & Focus Difficulties

C

Research suggests omega-3 supplementation may help improve attention and reduce impulsivity. Benefits appear more pronounced in individuals with lower baseline omega-3 levels.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dattention\u002Dfocus'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

Research suggests omega-3 supplementation may help improve attention and reduce impulsivity. Benefits appear more pronounced in individuals with lower baseline omega-3 levels.

Key Study Findings

Other
An HPLC-MS-Based Method for Determination of the D- and L- 5-Methyltetrahydrofolate Isomer Ratio in Dietary …
Dose: None vs: None Outcome: separation and quantification of D- and L-5-MTHF diastereomers … 効果: None None

対象集団: None

Review n=321
Current Evidence of Ergogenic and Post-Exercise Recovery Effects of Dietary Supplementation with Cordyceps militaris in …
Dose: None vs: None Outcome: None 効果: None None

対象集団: healthy individuals aged 16-35 from 5 intervention studies (2017-2024)

Other
Choline in Pediatric Nutrition: Assessing Formula, Fortifiers and Supplements Across Age Groups and Clinical Indications.
Dose: None vs: None Outcome: Choline content assessment across pediatric products 効果: None None

対象集団: Preterm/term infants and children with CF/kidney disease

Systematic Review
Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review.
Dose: None vs: None Outcome: Neurological health outcomes 効果: None None

対象集団: None

Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None vs: None Outcome: None 効果: None None

対象集団: None

Meta-Analysis
The Effect of Dietary Supplements on Male Infertility in Terms of Pregnancy, Live Birth, and …
Dose: None vs: Placebo Outcome: Pregnancy, live birth, sperm parameters 効果: None None

対象集団: Infertile males (50 RCTs, >=12 weeks)

Key Statistics

10

研究数

1800

参加者数

Positive

C

グレード

Referenced Papers

Newborn (Clarksville, Md.) 2024 9 件の引用
Indian dermatology online … 2021 17 件の引用
Journal of pain … 2020 56 件の引用
Psychiatrike = Psychiatriki 2020 15 件の引用
Clinical pharmacokinetics 2018 128 件の引用
Nutricion hospitalaria 2018 32 件の引用
Journal of ethnopharmacology 2017 98 件の引用
Stem cell investigation 2017 27 件の引用
Ageing research reviews 2016 142 件の引用
Cannabis and cannabinoid … 2016 77 件の引用
Journal of analytical … 2016 49 件の引用
Child and adolescent … 2014 42 件の引用
Der Nervenarzt 2014 7 件の引用
Advances in nutrition … 2013 155 件の引用
American journal of … 2011 17 件の引用
European review for … 2011 9 件の引用
Biological research for … 2010 49 件の引用
The Cochrane database … 2009 299 件の引用
The Cochrane database … 2007 375 件の引用
Sleep medicine reviews 2007 150 件の引用
International journal of … 2005 22 件の引用
Journal of clinical … 2004 205 件の引用
The Cochrane database … 2003 263 件の引用
Journal of Alzheimer's … 2003 161 件の引用
Neurochemical research 2003 82 件の引用
The British journal … 2001 166 件の引用
Pharmacological research 1999 1060 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

上限量: 3,000 mg/day combined DHA/EPA (FDA GRAS)

研究で検討された用量

用量 期間 効果 N
None -- Neutral --
None -- Mixed 321
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
1000 mg ferric carboxymaltose -- Positive 58
None -- Mixed --

推奨摂取タイミング: With meals containing fat for better absorption

Safety & Side Effects

報告されている副作用

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

既知の相互作用

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

耐容上限摂取量: 3,000 mg/day combined DHA/EPA (FDA GRAS)

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Attention & Focus Difficulties?
Based on 10 studies with 1,800 participants, there is limited but promising evidence that Omega-3 Fatty Acids (DHA/EPA) may support Attention & Focus Difficulties management. Our evidence grade is C (Some Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Attention & Focus Difficulties?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Attention & Focus Difficulties?
We rate the evidence as Grade C (Some Evidence). This rating is based on 10 peer-reviewed studies with 1,800 total participants. The overall direction of effect is positive.

Related Evidence

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。